Axsome Therapeutics, Inc.AXSMNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-272.60M
↓ 157% below average
Average (9y)
$-106.22M
Historical baseline
Range
High:$-9.19M
Low:$-272.60M
CAGR
+45.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-272.60M | -21.2% |
| 2023 | $-224.99M | -28.3% |
| 2022 | $-175.40M | -40.7% |
| 2021 | $-124.63M | -24.2% |
| 2020 | $-100.31M | -49.3% |
| 2019 | $-67.21M | -106.3% |
| 2018 | $-32.58M | -17.3% |
| 2017 | $-27.77M | -0.9% |
| 2016 | $-27.52M | -199.4% |
| 2015 | $-9.19M | - |